TwoStep Therapeutics
PrivateLast Round
Series A
Sep 9, 2026
Est. Valuation
$64.5M
Total Funding Raised
$92.3M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
TwoStep Therapeutics is a biotechnology company developing a pipeline of targeted cancer therapies for solid tumors using a unique polyspecific integrin-binding peptide (PIP) that selectively binds to multiple targets highly expressed on solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TwoStep Therapeutics Comparables
Compare TwoStep Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Actithera | 88% | |
| ARTBIO | 88% | |
| Ariceum Therapeutics | 88% |
TwoStep Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 9, 2026 | ||||
| Series A | Jan 20, 2026 | ||||
| Seed | Mar 19, 2025 | ||||
| Seed | Jun 25, 2024 |
Key People
Founding team and executive leadership
TwoStep Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Series A, Seed |
| M Ventures | Series A |
| Medical Excellence Capital | Series A |
| Alexandria Venture Investments | Seed |
| 2048 Ventures | Seed, Series A |
| Cooley | Seed |
| Pfizer Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2026
$63M round with participation from M Ventures and Pfizer Ventures.
- Jun 30, 2026
Grew 38% QoQ from 8 to 11 employees.
Recent news
Latest coverage and updates
- receives_financingSep 9, 2026
Twosteptx received financing of $62.5M in Series A on Sep 9th '26.
TwoStep Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TwoStep Therapeutics's valuation, stock price, and market status.
Is TwoStep Therapeutics a public or private company?
TwoStep Therapeutics is a private company.
What is the current stock price of TwoStep Therapeutics?
TwoStep Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is TwoStep Therapeutics worth (valuation)?
Valuation information for TwoStep Therapeutics is not publicly available.
Can I buy TwoStep Therapeutics stock?
TwoStep Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TwoStep Therapeutics's last funding round?
TwoStep Therapeutics's most recent funding round was Seed on March 19, 2025.
Who are the main investors in TwoStep Therapeutics?
Key investors in TwoStep Therapeutics include NFX.
Will TwoStep Therapeutics IPO soon?
No public IPO plans have been announced for TwoStep Therapeutics.
How can I track TwoStep Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TwoStep Therapeutics's secondary market activity and sign up for updates.